Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19

June 08, 2020 01:09:16
Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19
MitoAction Expert Series
Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19

Jun 08 2020 | 01:09:16

/

Show Notes

Join MitoAction and Dr. Richard Frye to discuss the distinction between primary and secondary mitochondrial diagnosis. Some talking points will include:

  • Primary mitochondrial disease (PMD) is ideally diagnosed by a known or indisputably pathogenic mitochondrial or nuclear DNA mutation.
  • Secondary mitochondrial dysfunction (SMD) can be caused by genes encoding either function nor production of the oxphos proteins and accompanies many heriditary non-mitochondrial diseases.
  • Secondary mitochondrial dysfunction (SMD) can also be caused by enviornmental factors.
  • In the absence of the ability to diagnose a primary mitochondrial disease (PMD), mitochondrial dysfunction can be effectively treated with standard treatments for PMD.
  • When the etiology of mitochondrial dysfunction is unknown, re-evaluation for genetic and other causes should be revisited on a regular basis.

About The Speaker:

Dr. Richard Frye is a pediatric neurologist and Chief of the Division of Neurodevelopmental Disorders at Phoenix Children’s Hospital.  He received his MD/PhD from Georgetown University in 1998. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University. He holds board certifications in Pediatrics, and in Neurology with Special Competence in Child Neurology. Dr. Frye is a national leader in autism research. He has authored over 100 peer-reviewed publications and book chapters, and serves on several editorial boards of scientific and medical journals.

Other Episodes

Episode

June 23, 2022 00:52:50
Episode Cover

Stealth BT Mitochondrial Myopathy Trial

Join us with Stealth BioTherapeutics CEO Travis Wilson and others from the Stealth BT team for a live update from Stealth BT (click here...

Listen

Episode

June 24, 2022 01:45:33
Episode Cover

2018 Mito Town Meeting

Organizations share what they have planned for the next 12 months. The annual town meeting is our way of kicking off the new year...

Listen

Episode 0

June 18, 2020 01:48:43
Episode Cover

Mitochondrial Genetics & Diseases - Dr. Doug Wallace - 6/1/18

Talking points include: The mtDNA has a unique quantitative genetics Different mtDNA mutations can result in very different symptoms The high copy number of...

Listen